Back to Top Skip to main content Skip to sub-navigation

COVID-19 Vaccine Efforts

On Aug. 23, 2021, the U.S. Food and Drug Administration issued formal licensure of the Pfizer-BioNTech COVID-19 vaccine, now called COMIRNATY®. This licensure is based on rigorous studies demonstrating efficacy and safety through data collected over the past year.

The Centers for Disease Control and Prevention (CDC) state their Advisory Committee on Immunization Practices uses a formal evidence process in their reviews, and holds public meetings where the evidence is reviewed before deliberation occurs. This process complements public deliberations carried out by the FDA’s Vaccines and Related Biological Products Advisory Committee.

Following CDC guidance, DOD will continue to adjust health protection protocols to the local conditions of the communities in which we serve. The Department’s priorities include:

  • Protecting our Service members, DOD civilians, and families
  • Safeguarding our national security capabilities
  • Supporting the whole-of-nation response to the COVID-19 pandemic

The CDC and the DOD recommend the COVID-19 vaccine for all people 5 years and older. Getting a COVID-19 vaccine helps protect you, your family, your community and our nation. Eligible and authorized TRICARE beneficiaries can make a COVID-19 vaccine appointment, as available, at a DOD vaccination site.

COVID-19 Vaccine Toolkit Page TRICARE Beneficiary Information

DOD Vaccine Mandates

Active Duty Service Members

DOD Civilian Employees

COVID-19 Vaccine Safety

COVID-19 vaccines authorized in the United States continue to be remarkably effective in reducing risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant.

The CDC confirms COVID-19 vaccines are safe and effective and recommend that all persons get COVID-19 vaccinations as soon as possible. In addition to the newly licensed Pfizer-BioNTech COVID-19 vaccine, now called COMIRNATY®, several COVID-19 vaccines have been offered through FDA’s Emergency Use Authorization.  

COVID-19 vaccine development has processes and procedures in place to help ensure the safety of any vaccine authorized for use. Vaccines for COVID-19 are only available after they are:

  • Demonstrated to be safe and effective in large phase three clinical trials
  • Authorized by the U.S. Food and Drug Administration
  • Manufactured and distributed safely and securely

Visit the CDC Website to learn more about COVID-19 vaccines.

You also may be interested in...

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

San Antonio volunteers sought for Warp Speed vaccine trials

Article
11/18/2020
Woman typing on laptop

DOD sites are open on a voluntary basis to Military Health System beneficiaries.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | Vaccine Trials | COVID-19 Vaccine Toolkit

Military Health System participating in COVID-19 vaccine trial

Article
11/17/2020
Woman measuring out a vaccine into a needle

How you can help test the vaccine.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | Vaccine Trials

BAMC, Argentine Army medical providers share COVID-19 best practices

Article
11/4/2020
Video teleconference image

U.S. Army South facilitated the virtual subject matter expert (SME) exchange between BAMC and CMMH.

Recommended Content:

Coronavirus | Global Health Engagement | Technology | COVID-19 Vaccine Efforts | Public Health | Convalescent Plasma Collection Program | COVID-19 Vaccine Toolkit

How Can Vaccine and Antibody Studies Move So Quickly and Still Be Safe?

Video
11/3/2020
How Can Vaccine and Antibody Studies Move So Quickly and Still Be Safe?

This video provides a detailed overview of the processes that have been implemented to accelerate the pace of the COVID-19 vaccine and antibody studies, and what is being done to assure safety.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

The Importance of Enrolling Diverse Participants in COVID-19 Studies

Video
11/3/2020
The Importance of Enrolling Diverse Participants in COVID-19 Studies

This video discusses why enrolling diverse participants in COVID-19 studies is critical for ensuring that, when we find a vaccine, we have enough data from populations who are most affected by COVID-19 to determine vaccine safety and efficacy.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | COVID-19 Vaccine Toolkit

Trump Administration Releases COVID-19 Vaccine Distribution Strategy

Article
9/17/2020
Soldier getting flu shot

Detailed planning is ongoing to ensure rapid distribution as soon as the FDA authorizes or approves a COVID-19 vaccine and CDC makes recommendations for who should receive initial doses.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Efforts

What is an EUA?

Video
4/28/2020
What is an EUA?

Emergency use authorizations (EUAs) are one of several tools the FDA is using to help make important medical products available quickly during the COVID-19 pandemic. But what exactly is an EUA?

Recommended Content:

COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit
<< < ... 11 12 13 > >> 
Showing results 181 - 189 Page 13 of 13

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.